De Guia, Juliet A.
HRN: 11-08-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
LEVOFLOXACIN 500MG (TAB)
01/17/2023
01/23/2023
ORAL
750 Mg
Q24H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes